Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands

Background: Recurrences remain an important problem in laryngeal squamous cell carcinoma. Little has been described about histological characteristics of the primary laryngeal tumor that may be associated with recurrences. Identifying risk factors for recurrences might help in adapting treatment or...

Full description

Bibliographic Details
Main Authors: Bruggink, A.H (Author), de Bree, R. (Author), Doornaert, P.A.H (Author), Philippens, M.E.P (Author), Ruiter, L.N (Author), van Dijk, B.A.C (Author), van Gils, C.H (Author), Willems, S.M (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03664nam a2200553Ia 4500
001 10.1186-s12885-022-09533-0
008 220510s2022 CNT 000 0 und d
020 |a 14712407 (ISSN) 
245 1 0 |a Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands 
260 0 |b BioMed Central Ltd  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1186/s12885-022-09533-0 
520 3 |a Background: Recurrences remain an important problem in laryngeal squamous cell carcinoma. Little has been described about histological characteristics of the primary laryngeal tumor that may be associated with recurrences. Identifying risk factors for recurrences might help in adapting treatment or follow-up. Using real-life population-based data, we aimed to identify histological features of the primary tumor associated with recurrences and overall survival. Material and methods: Demographic, clinical and treatment information on all first primary invasive laryngeal tumors diagnosed in 2010–2014 (N = 3705) were extracted from the population-based nationwide Netherlands cancer registry (NCR) and linked to PALGA, the nationwide Dutch pathology registry, to obtain data on histological factors and recurrences. For a random 1502 patients histological information i.e., keratinization, perineural invasion (PNI+), vascular invasion (VI+), growth pattern, degree of differentiation, extracapsular spread (ECS+), cartilage- and bone invasion and extralaryngeal extension, was manually extracted from narrative pathology reports and analyzed for locoregional recurrence and overall survival using cox regression analysis. Results: In total, 299 patients developed a locoregional recurrence and 555 patients died. Keratinization (HR = 0.96 (95%CI: 0.68–1.34) p = 0.79), two or three adverse characteristics (PNI+, VI+, non-cohesive growth) (HR = 1.38 (95% CI: 0.63–3.01) p = 0.42), and ECS+ (HR = 1.38 (95% CI: 0.48–4.02) p = 0.55) were not associated to recurrence. For death, also no significant association was found. Conclusion: In this population-based real-life dataset on laryngeal carcinoma in the Netherlands, histological factors were not associated with locoregional recurrences or overall survival, but future studies should investigate the role of these features in treatment decisions. © 2022, The Author(s). 
650 0 4 |a cancer staging 
650 0 4 |a Carcinoma, Squamous Cell 
650 0 4 |a epidemiology 
650 0 4 |a Head and Neck Neoplasms 
650 0 4 |a head and neck tumor 
650 0 4 |a Histology 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Laryngeal neoplasms 
650 0 4 |a Laryngeal Neoplasms 
650 0 4 |a larynx tumor 
650 0 4 |a Neoplasm Invasiveness 
650 0 4 |a Neoplasm Recurrence, Local 
650 0 4 |a Neoplasm Staging 
650 0 4 |a Netherlands 
650 0 4 |a pathology 
650 0 4 |a Pathology 
650 0 4 |a prognosis 
650 0 4 |a Prognosis 
650 0 4 |a Recurrence 
650 0 4 |a Retrospective Studies 
650 0 4 |a retrospective study 
650 0 4 |a squamous cell carcinoma 
650 0 4 |a Squamous Cell Carcinoma of Head and Neck 
650 0 4 |a Squamous cell carcinoma 
650 0 4 |a Survival 
650 0 4 |a tumor invasion 
650 0 4 |a tumor recurrence 
700 1 |a Bruggink, A.H.  |e author 
700 1 |a de Bree, R.  |e author 
700 1 |a Doornaert, P.A.H.  |e author 
700 1 |a Philippens, M.E.P.  |e author 
700 1 |a Ruiter, L.N.  |e author 
700 1 |a van Dijk, B.A.C.  |e author 
700 1 |a van Gils, C.H.  |e author 
700 1 |a Willems, S.M.  |e author 
773 |t BMC Cancer